Microbiología clínica y enfermedades Infecciosas

Bouza, E; Munoz, P; Burillo, A.

The role of tedizolid in skin and soft tissue infections

CURRENT OPINION IN INFECTIOUS DISEASES. 2018; 31(2): 131-140 Nº de citas: 16 [doi:10.1097/QCO.0000000000000439]

Espinel-Ingroff, A; Turnidge, J; Alastruey-Izquierdo, A; Dannaoui, E; Garcia-Effron, G; Guinea, J; Kidd, S; Pelaez, T; Sanguinetti, M; Meletiadis, J; Botterel, F; Bustamante, B; Chen, YC; Chakrabarti, A; Chowdhary, A; Chryssanthou, E; Cordoba, S; Gonzalez, GM; Guarro, J; Johnson, EM; Kus, JV; Lass-Florl, C; Linares-Sicilia, MJ; Martin-Mazuelos, E; Negri, CE; Pfaller, MA; Tortorano, AM.

Posaconazole MIC Distributions for Aspergillus fumigatus Species Complex by Four Methods: Impact of cyp51A Mutations on Estimation of Epidemiological Cutoff Values

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2018; 62(4): Nº de citas: 37 [doi:10.1128/AAC.01916-17]

Reigadas, E; Alcala, L; Gomez, J; Marin, M; Martin, A; Onori, R; Munoz, P; Bouza, E.

Breakthrough Clostridium difficile Infection in Cirrhotic Patients Receiving Rifaximin

CLINICAL INFECTIOUS DISEASES. 2018; 66(7): 1086-1091 Nº de citas: 29 [doi:10.1093/cid/cix918]

Gutierrez-Pizarraya, A; Martin-Villen, L; Alcala-Hernandez, L; Arriaza, MM; Balandin-Moreno, B; Aragon-Gonzalez, C; Ferreres-Franco, J; Monleon, MAC; Anguita-Alonso, P; Bouza-Santiago, E; Garnacho-Montero, J.

Epidemiology and risk factors for Clostridium difficile infection in critically ill patients in Spain: The PROCRID study

ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA. 2018; 36(4): 218-221 Nº de citas: 5 [doi:10.1016/j.eimc.2017.01.007]

Coll, P; de Viedma, DG.

Molecular epidemiology of tuberculosis

ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA. 2018; 36(4): 233-240 Nº de citas: 11 [doi:10.1016/j.eimc.2018.01.001]

Bouza, E; Valerio, M; Soriano, A; Morata, L; Carus, EG; Rodriguez-Gonzalez, C; Hidalgo-Tenorio, MC; Plata, A; Munoz, P; Vena, A.

Dalbavancin in the treatment of different gram-positive infections: a real-life experience

International Journal of Antimicrobial Agents. 2018; 51(4): 571-577 Nº de citas: 142 [doi:10.1016/j.ijantimicag.2017.11.008]

Rivoisy, C; Vena, A; Schaeffer, L; Charlier, C; Fontanet, A; Delahaye, F; Bouza, E; Lortholary, O; Munoz, P; Lefort, A; French Mycoses Study Grp; Grp Apoyo Manejo Endocarditis Espa.

Prosthetic Valve Candida spp. Endocarditis: New Insights Into Long-term Prognosis-The ESCAPE Study

CLINICAL INFECTIOUS DISEASES. 2018; 66(6): 825-832 Nº de citas: 52 [doi:10.1093/cid/cix913]

Alonso B; Cruces R; Perez A; Fernandez-Cruz A; Guembe M.

Activity of maltodextrin and vancomycin against staphylococcus aureus biofilm.

Frontiers in Bioscience - Scholar. 2018; 10: 300-308

Alonso, R; Perez-Garcia, F; Lopez-Roa, P; Alcala, L; Rodeno, P; Bouza, E.

HCV core-antigen assay as an alternative to HCV RNA quantification: A correlation study for the assessment of HCV viremia

ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA. 2018; 36(3): 175-178 Nº de citas: 25 [doi:10.1016/j.eimc.2016.11.013]

Bordallo-Cardona, MA; Marcos-Zambrano, LJ; Sanchez-Carrillo, C; de la Pedrosa, EGG; Canton, R; Bouza, E; Escribano, P; Guinea, J.

Mutant Prevention Concentration and Mutant Selection Window of Micafungin and Anidulafungin in Clinical Candida glabrata Isolates

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2018; 62(3): Nº de citas: 16 [doi:10.1128/AAC.01982-17]

Munoz, P; Vena, A; Machado, M; Gioia, F; Martinez-Jimenez, MC; Gomez, E; Origuen, J; Orellana, MA; Lopez-Medrano, F; Fernandez-Ruiz, M; Merino, P; Gonzalez-Romo, F; Frias, I; Perez-Granda, MJ; Aguado, JM; Fortun, J; Bouza, E.

T2Candida MR as a predictor of outcome in patients with suspected invasive candidiasis starting empirical antifungal treatment: a prospective pilot study

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2018; 73: 6-12 Nº de citas: 51 [doi:10.1093/jac/dky047]

Munoz, P; Vena, A; Machado, M; Martinez-Jimenez, MC; Gioia, F; Gomez, E; Origuen, J; Orellana, MA; Lopez-Medrano, F; Perez-Granda, MJ; Aguado, JPM; Fortun, J; Bouza, E.

T2MR contributes to the very early diagnosis of complicated candidaemia. A prospective study

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2018; 73: 13-19 Nº de citas: 31 [doi:10.1093/jac/dky048]

Abdala, E; Miller, R; Pasqualotto, AC; Muñoz P; Colombo, AL; Cuenca-Estrella, M.

Endemic Fungal Infection Recommendations for Solid-Organ Transplant Recipients and Donors

TRANSPLANTATION. 2018; 102(2): 52-59 Nº de citas: 15 [doi:10.1097/TP.0000000000002020]

Munoz, L; Santin, M; Alcaide, F; Ruiz-Serrano, MJ; Gijon, P; Bermudez, E; Dominguez-Castellano, A; Navarro, MD; Ramirez, E; Perez-Escolano, E; Lopez-Prieto, MD; Gutierrez-Rodriguez, J; Anibarro, L; Calvino, L; Trigo, M; Cifuentes, C; Garcia-Gasalla, M; Payeras, A; Gasch, O; Espasa, M; Aguero, R; Ferrer, D; Cases, X; Gonzalez-Cuevas, A; Garcia-Zamalloa, A; Bikuna, E; Lecuona, M; Galindo, R; Ramirez-Lapausa, M; Carrillo, R.

QuantiFERON-TB Gold In-Tube as a Confirmatory Test for Tuberculin Skin Test in Tuberculosis Contact Tracing: A Noninferiority Clinical Trial

CLINICAL INFECTIOUS DISEASES. 2018; 66(3): 396-403 Nº de citas: 15 [doi:10.1093/cid/cix745]

Lopez-Medrano, F; Fernandez-Ruiz, M; Silva, JT; Carver, PL; van Delden, C; Merino, E; Perez-Saez, MJ; Montero, M; Coussement, J; Mazzolin, MD; Cervera, C; Santos, L; Sabe, N; Scemla, A; Cordero, E; Cruzado-Vega, L; Martin-Moreno, PL; Len, O; Rudas, E; de Leon, AP; Arriola, M; Lauzurica, R; David, MD; Gonzalez-Rico, C; Henriquez-Palop, F; Fortun, J; Nucci, M; Manuel, O; Pano-Pardo, R; Montejo, M; Vena, A; Sanchez-Sobrino, B; Mazuecos, A; Pascual, J; Horcajada, JP; Lecompte, T; Moreno, A; Carratala, J; Blanes, M; Hernandez, D; Hernandez-Mendez, EA; Farinas, MC; Perello-Carrascosa, M; Munoz, P; Andres, A; Aguado, JM; Spanish Network Res Infect Dis; Spanish Soc Clin Microbiol & Infe; European Soc Clin Microbiol & Infe; Swiss Transplant Cohort Study STCS.

Multinational case-control study of risk factors for the development of late invasive pulmonary aspergillosis following kidney transplantation

CLINICAL MICROBIOLOGY AND INFECTION. 2018; 24(2): 192-198 Nº de citas: 76 [doi:10.1016/j.cmi.2017.06.016]

Chaves, F; Garnacho-Montero, J; del Pozo, JL; Souza, E; Capdevila, JA; de Cueto, M; Dominguez, MA; Esteban, J; Fernandez-Hidalgo, N; Sampedro, MF; Fortun, J; Guembe, M; Lorente, L; Pano, JR; Ramirez, P; Salavert, M; Sanchez, M; Valles, J.

Executive summary: Diagnosis and Treatment of Catheter-Related Bloodstream Infection: Clinical Guidelines of the Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC) and the Spanish Society of Intensive Care Medicine and Coronary Units (SEMICYUC).

Medicina Intensiva. 2018; 36(2): 112-119 Nº de citas: 30 [doi:10.1016/j.eimc.2017.10.019]

Ramirez, ER; Bouza, ES.

Economic Burden of Clostridium difficile Infection in European Countries

Advances in Experimental Medicine and Biology. 2018; 1050: 1-12 Nº de citas: 32 [doi:10.1007/978-3-319-72799-8_1]

Fortea, JI; Zipprich, A; Fernandez-Mena, C; Puerto, M; Bosoi, CR; Almagro, J; Hollenbach, M; Banares, J; Rodriguez-Sanchez, B; Cercenado, E; Clement, MA; Rose, CF; Banares, R; Vaquero, J; Ripoll, C.

Enoxaparin does not ameliorate liver fibrosis or portal hypertension in rats with advanced cirrhosis

LIVER INTERNATIONAL. 2018; 38(1): 102-112 Nº de citas: 15 [doi:10.1111/liv.13510]